Clinical Trial Update: Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposome-encapsulated doxorubicin citrate in combination with carboplatin for advanced or metastatic recurrent endometrial can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Liposome-encapsulated doxorubicin citrate (doxorubicin citrate liposome)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN